Lancaster Medical Center earns key accreditation, approval for cardiac care
Penn State Health Lancaster Medical Center has received accreditation for percutaneous coronary intervention — a minimally invasive procedure to open narrowed coronary arteries — from Accreditation for Cardiovascular Excellence (ACE). The organization is dedicated to ensuring the highest quality standards for cardiovascular and endovascular care. To earn this accreditation, Lancaster Medical Center underwent a rigorous review of its structure, internal processes, patient safety practices and clinical outcomes against nationally accepted best-practice standards.
Additionally, the Pennsylvania Department of Health (DOH) recently approved Lancaster Medical Center to offer the automated implantable cardiac defibrillator to patients at high risk of sudden cardiac death. The implantable device controls abnormal heart rhythms.
“Our expert care team has worked tirelessly to bring life-saving care and the newest, most effective technology to our patients,” said Dr. Patrick Fitzsimmons, an interventional cardiologist at Lancaster Medical Center. “We are proud to have our efforts recognized by ACE and supported by the DOH.”
Lancaster Medical Center has a state-of-the-art hybrid operating room equipped with advanced imaging technology that allows surgeons to perform both minimally invasive and open vascular surgeries. The hospital also features three cardiac catheterization labs to diagnose and treat certain heart conditions without surgery. Patients have enhanced access to the advanced care and clinical trials available at Penn State Health Milton S. Hershey Medical Center and Penn State College of Medicine in Hershey.
If you're having trouble accessing this content, or would like it in another format, please email Penn State Health Marketing & Communications.